A teenager from British Columbia has successfully overcome a rare disease thanks to advanced prime editing gene technology. This method, which allows for precise changes to DNA, minimizes the risk of genetic disorders compared to traditional methods that involve double-strand breaks. The groundbreaking therapy helped Tai Sperl, who suffered from a chronic granulomatous disease that required daily antibiotics and antifungal medications.
According to Global News, Tai became the first person in the world to receive prime editing as a treatment method. His condition was diagnosed at the age of five, and for 14 years he had to rely on medications to maintain his health. Despite the need for a bone marrow transplant, a suitable donor could not be found.
Tai participated in a pilot clinical trial aimed at determining the effectiveness and safety of prime editing for treating rare genetic disorders. During the treatment, his blood stem cells were extracted, edited without the use of double-strand breaks, and then returned to his body.
The treatment results were impressive: Tai's immune function quickly recovered, and the procedure was completed without complications. Similar treatment was also conducted for another patient, who also fully recovered.
"I have taken a lot of pills my whole life, and now that is in the past. I no longer need to take medication — it's amazing," Tai shared his impressions.
Scientists call these achievements a significant step forward for the healthcare system, opening new horizons for families facing rare genetic diseases.
